Abstract:BACKGROUND: Venous thromboembolism occurs in approximately 2% of patients undergoing abdominal and pelvic surgery for cancers of the colon, rectum, and anus, and is considered preventable. The American Society of Colon and Rectal Surgeons recommends extended prophylaxis in high-risk patients, but there is low adherence to the guidelines. OBJECTIVE: This study aims to analyze the impact of venous thromboembolism risk-guided prophylaxis in patients undergoing elective abdominal and pelvic surgeries for colorectal and anal cancers from 2016 to 2021. DESIGN: This was a retrospective analysis. SETTING: The study was conducted at a multisite tertiary referral academic healthcare system. PATIENTS: Patients who underwent elective abdominal or pelvic surgery for colon, rectal or anal cancer. MAIN OUTCOME MEASURES: Receipt of Caprini-guided venous thromboembolism prophylaxis, 90 days postoperative rate of deep vein thrombosis, pulmonary embolism, venous thromboembolism, and bleeding events. RESULTS: A total of 3,504 patients underwent elective operations, of which 2,224 (63%) received appropriate thromboprophylaxis in the inpatient setting. In the post-discharged cohort of 2,769 patients, only 2% received appropriate thromboprophylaxis in which no thromboembolic events were observed. In the group receiving inappropriate thromboprophylaxis, at 90 days post-discharge, the deep vein thrombosis, pulmonary embolism, and venous thromboembolism rates were 0.60%, 0.40%, and 0.88%, respectively. Postoperative bleeding was not different between the two groups. LIMITATIONS: Limitations to our study include its retrospective nature, use of aggregated electronic medical records, and single healthcare system experience. CONCLUSION: Most patients in our healthcare system undergoing abdominal or pelvic surgery for cancers of the colon, rectum, and anus were discharged without appropriate Caprini-guided VTE prophylaxis. Risk-guided prophylaxis was associated with decreased rates of in-hospital and discharged venous thromboembolism without an increase in bleeding complications. See Video Abstract .

S73 Anticoagulation in Acute Pancreatitis Related Thrombosis: Practice Variations

Venous Thrombosis in Acute Pancreatitis: What to and Not to Do?

S57 Utilization of Oral Anticoagulants for Acute Splenic Infarction in the Setting of Pancreatitis: A Systematic Review

Efficacy and Safety of Early Systemic Anticoagulation for Preventing Splanchnic Thrombosis in Acute Necrotizing Pancreatitis.

Catheter-directed thrombolysis versus systemic anticoagulation in the treatment of symptomatic splanchnic venous thrombosis secondary to acute pancreatitis: a retrospective cohort study

Splanchnic Vein Thrombosis Secondary to Severe Acute Pancreatitis Treated with Regional Anticoagulation Via Transjugular Intrahepatic Portosystem Stent-Shunt

Splanchnic vein thrombosis in necrotizing pancreatitis: a post-hoc analysis of a nationwide prospective cohort

Practice Guidance for Diagnosis and Treatment of Pancreatitis-Related Splanchnic Vein Thrombosis (shenyang, 2020)

Risk adjusted venous thromboembolism prophylaxis following pancreatic surgery

S153 Risk of Venous Thromboembolism in Acute Necrotizing Pancreatitis: A Propensity-Matched Analysis From a Multicenter US Cohort Study

Risk Factors and Outcome of Splanchnic Venous Thrombosis in Patients with Necrotizing Acute Pancreatitis.

Anticoagulant therapy for splanchnic vein thrombosis

The risk of developing splanchnic vein thrombosis in acute pancreatitis increases 3 days after symptom onset: A systematic review and meta‐analysis

Glyceryl Trinitrate For Prevention Of Post-Ercp Pancreatitis And Improve The Rate Of Cannulation: A Meta-Analysis Of Prospective, Randomized, Controlled Trials

Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis

Portosplenomesenteric vein thrombosis in patients with early-stage severe acute pancreatitis

Early systemic anticoagulation reduces hospital readmission in acute necrotizing pancreatitis patients: A retrospective cohort study

Prevalence, treatment efficacy, and risk factors of vascular complications in acute pancreatitis: A case–control study

Discordant reporting of VTE in pancreatic cancer: A systematic review and meta-analysis of thromboprophylaxis versus chemotherapeutic trials

Vascular complications of chronic pancreatitis: A tertiary center experience

Room for Improvement: The Impact of Guideline-Recommended Extended Thromboprophylaxis in Patients Undergoing Abdominal Surgery for Colorectal and Anal Cancer at a Tertiary Referral Center